𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies

✍ Scribed by Fuchs, T. A.; Kremer Hovinga, J. A.; Schatzberg, D.; Wagner, D. D.; Lammle, B.

Book ID
121827369
Publisher
American Society of Hematology
Year
2012
Tongue
English
Weight
486 KB
Volume
120
Category
Article
ISSN
0006-4971

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ADAMTS13 activity levels in patients wit
ADAMTS13 activity levels in patients with human immunodeficiency virus-associated thrombotic microangiopathy and profound CD4 deficiency
✍ Yara A. Park; Shauna N. Hay; Mark E. Brecher πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract ## Background: Thrombotic microangiopathy (TMA) encompasses a number of disorders with hemolytic anemia and thrombocytopenia, including thrombotic thrombocytopenic purpura (TTP). A deficiency in ADAMTS13 enzyme levels, along with an inhibitory antibody, is found in most patients with i

Inherited DNA mutations contributing to
Inherited DNA mutations contributing to thrombotic complications in patients with Sickle cell disease
✍ Zimmerman, Sherri A.; Ware, Russell E. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 545 KB

Thrombosis may play an important role in the pathophysiology of certain complications of sickle cell disease (SCD), including stroke and avascular necrosis (AVN). Currently there is no laboratory or clinical parameter that can identify patients who are at highest risk of developing these thrombotic